Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Time from prior chemotherapy (TFPC) as a...
Journal article

Time from prior chemotherapy (TFPC) as a prognostic factor in advanced urothelial carcinoma (UC) receiving second-line systemic therapy.

Abstract

4522

Authors

Pond GR; Sonpavde G; Choueiri TK; Qu AQ; Vaughn DJ; Fougeray R; Niegisch G; Albers P; Wong Y-N; Ko Y-J

Journal

Journal of Clinical Oncology, Vol. 30, No. 15_suppl, pp. 4522–4522

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2012

DOI

10.1200/jco.2012.30.15_suppl.4522

ISSN

0732-183X